Combination pembrolizumab and reduced-dose ipilimumab: how low can you go?
Renal cell carcinoma: the Emulsion and CheckMate 214 trials
How is treatment determined in renal cell carcinoma?
Current landscape and future direction in systemic therapy for renal cell carcinoma (RCC)
The risks of combining therapies in renal cell carcinoma and bladder cancer